The HIF1α, VEGF and associated pathways are linked to poor prognosis in a range of solid tumours (Hegde et al., 2013; Lundgren et al., 2007; Semenza, 2016), demonstrating the consequences of tumour hypoxia on patient outcome. The gene discussed is VEGFA; the disease is neoplasm.